Contribute Try STAT+ Today

Securing a billion dollars of yearly funding was once considered a landmark achievement in health tech. But with the pandemic fueling a resurgence in interest for virtual care, those days are long gone.

Since late last year, activity in the digital health sector has broken virtually every financial record, from funding to acquisitions and deals to go public. This quarter, which starts on Thursday, is expected to see the frenzied trend continue in lockstep with a flurry of industry conferences and events, all of which are currently slated to take place virtually.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.